US BANCORP \DE\ - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2020$9,000
+200.0%
2,851
+143.5%
0.00%
Q1 2020$3,0000.0%1,1710.0%0.00%
Q4 2019$3,000
+200.0%
1,171
+57.0%
0.00%
Q3 2019$1,000
-50.0%
7460.0%0.00%
Q2 2019$2,0000.0%746
+31.6%
0.00%
Q1 2019$2,000
-33.3%
567
-43.3%
0.00%
Q1 2018$3,000
+200.0%
1,000
+233.3%
0.00%
Q2 2017$1,0000.0%3000.0%0.00%
Q1 2017$1,0000.0%3000.0%0.00%
Q4 2016$1,000
-66.7%
300
-62.9%
0.00%
Q3 2016$3,000
-25.0%
809
-33.1%
0.00%
Q2 2016$4,0000.0%1,2090.0%0.00%
Q1 2016$4,000
+100.0%
1,209
+72.7%
0.00%
Q4 2015$2,000
-50.0%
7000.0%0.00%
Q3 2015$4,000
-75.0%
700
-72.4%
0.00%
Q2 2015$16,000
-52.9%
2,533
-46.2%
0.00%
Q1 2015$34,000
-61.8%
4,708
-59.3%
0.00%
Q4 2014$89,000
+4.7%
11,576
+1.9%
0.00%
Q3 2014$85,000
-30.3%
11,358
-10.3%
0.00%
Q2 2014$122,000
+15.1%
12,6680.0%0.00%
Q1 2014$106,000
+12.8%
12,668
+14.1%
0.00%
Q4 2013$94,000
+1075.0%
11,098
+1009.8%
0.00%
Q3 2013$8,0000.0%1,0000.0%0.00%
Q2 2013$8,0001,0000.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Silver Point Capital L.P. 23,783,273$58,745,0006.82%
Park West Asset Management LLC 14,397,212$35,561,0000.74%
GABELLI & Co INVESTMENT ADVISERS, INC. 633,700$1,565,0000.24%
JBF Capital, Inc. 543,990$1,344,0000.22%
Context Capital Management, LLC 465,172$1,149,0000.16%
Bellecapital International Ltd. 108,025$267,0000.09%
FNY Investment Advisers, LLC 100,000$247,0000.07%
WINTON GROUP Ltd 291,360$720,0000.05%
Freedom Investment Management, Inc. 54,735$135,0000.02%
HANCOCK WHITNEY CORP 187,757$464,0000.02%
View complete list of PDL BIOPHARMA INC shareholders